8-Hydroxyquinoline → tert-Butyl 8-(2-oxo-4-(5-(trifluoromethyl)pyridin-2-yl)pyridin-1(2H)-yl)-6-tosyl-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate

HRID 474926Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 474926
Br[C:2]1[CH:3]=[CH:4][C:5]2[C:6]3[CH2:25][N:24]([C:26]([O:28][C:29]([CH3:32])([CH3:31])[CH3:30])=[O:27])[CH2:23][CH2:22][CH2:21][C:7]=3[N:8]([S:11]([C:14]3[CH:20]=[CH:19][C:17]([CH3:18])=[CH:16][CH:15]=3)(=[O:13])=[O:12])[C:9]=2[CH:10]=1.[F:33][C:34]([F:49])([F:48])[C:35]1[CH:36]=[CH:37][C:38]([C:41]2[CH:46]=[CH:45][NH:44][C:43](=[O:47])[CH:42]=2)=[N:39][CH:40]=1.C([O-])([O-])=O.[Cs+].[Cs+].OC1C=CC=C2C=1N=CC=C2>CS(C)=O.[Cu](I)I>[O:47]=[C:43]1[CH:42]=[C:41]([C:38]2[CH:37]=[CH:36][C:35]([C:34]([F:49])([F:33])[F:48])=[CH:40][N:39]=2)[CH:46]=[CH:45][N:44]1[C:2]1[CH:3]=[CH:4][C:5]2[C:6]3[CH2:25][N:24]([C:26]([O:28][C:29]([CH3:32])([CH3:31])[CH3:30])=[O:27])[CH2:23][CH2:22][CH2:21][C:7]=3[N:8]([S:11]([C:14]3[CH:20]=[CH:19][C:17]([CH3:18])=[CH:16][CH:15]=3)(=[O:13])=[O:12])[C:9]=2[CH:10]=1

Komponenten

7

Reaktionsbedingungen

Temperatur
130 °C

Versuchsvorschrift

tert-Butyl 8-bromo-6-tosyl-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate (0.20 g, 0.39 mmol), 4-(5-(trifluoromethyl)pyridin-2-yl)pyridin-2(1H)-one (0.10 g, 0.43 mmol) and Cs2CO3 (0.14 g, 0.43 mmol) were suspended in DMSO (2.3 mL), and the air was removed under vacuum for 15 min. The system was flushed with Ar, and 8-hydroxyquinoline (17 mg, 0.12 mmol) and copper iodide (985 mg, 0.50 mmol) were added to the suspension. The evacuation/Ar flushing process was repeated twice more, and the reaction mixture was heated at 130° C. for 18 h under N2. The solution was cooled, diluted with 5:1 MeOH/NH4OH (15 mL), and the resulting solution was stirred at ambient temperature for 30 min. The reaction was further diluted with CH2Cl2 (50 mL). The resulting solution was filtered through silica gel, and the filtrate was concentrated under reduced pressure. The residue was diluted with CH2Cl2 and washed with brine (3×25 mL). The organic solution was dried over Na2SO4, filtered and concentrated to dryness. Flash chromatography (12 g ISCO column, (1:1 hexanes/EtOAc)/(80:18:2 CH2Cl2/MeOH/NH4OH), 100:0 for 5 column volumes, increased to 50:50 over 20 column volumes and held for 5 column volumes; increased to 0:100 over 10 column volumes and held for 8 column volumes) gave the title compound (98 mg, 37%) as a yellow film: 1H NMR (300 MHz, DMSO-d6) δ 9.16 (s, 1H), 8.40-8.38 (m, 2H), 8.23-8.18 (m, 1H), 7.93 (d, J=7.2 Hz, 1H), 7.75-7.65 (m, 3H), 7.39-7.33 (m, 4H), 7.12 (dd, J=7.2, 1.8 Hz, 1H), 4.48 (s, 2H), 3.61-3.60 (m, 2H), 3.33-3.27 (m, 2H), 2.31 (s, 3H), 1.89-1.88 (m, 2H), 1.30-1.08 (m, 9H).

Aufarbeitung

  1. customthe air was removed under vacuum for 15 min
  2. additionwere added to the suspension
  3. customThe evacuation/Ar flushing process
  4. temperatureThe solution was cooled
  5. additiondiluted with 5:1 MeOH/NH4OH (15 mL)
  6. additionThe reaction was further diluted with CH2Cl2 (50 mL)
  7. filtrationThe resulting solution was filtered through silica gel
  8. concentrationthe filtrate was concentrated under reduced pressure
  9. additionThe residue was diluted with CH2Cl2
  10. washwashed with brine (3×25 mL)
  11. dry with materialThe organic solution was dried over Na2SO4
  12. filtrationfiltered
  13. concentrationconcentrated to dryness
  14. temperatureFlash chromatography (12 g ISCO column, (1:1 hexanes/EtOAc)/(80:18:2 CH2Cl2/MeOH/NH4OH), 100:0 for 5 column volumes, increased to 50:50 over 20 column volumes and held for 5 column volumes; increased to 0:100 over 10 column volumes and held for 8 column volumes)

Quellen und Nachweise

ORD-Eintrag
ord-bc4ea592274b46528ea3e9e04cc5e272
Quelldatensatz
uspto-grants-2014_01
Patentnummer
US08637501B2

Notizen zur Reaktion

Wird geladen…